One Platform. Three Ways to Capture.
A single unified biosensor platform captures biological signals from patients & environments across three modalities.
Swab
Clinical Beachhead
Reimbursable point-of-care diagnostic; fastest path to FDA clearance and revenue.
Breath
Field & Mass Screening
Non-invasive, deployed for institutional and government mass screening contracts — Varro’s second diagnostic product via the De Novo pathway
Air
Real-Time Surveillance
Subscription-based monitoring contracts. Each deployed node feeds the population-scale data network.
Critical Decisions are Made Without Continuous Biological Data
Critical decisions are made without continuous biological data
Exciting Things are Happening at Varro!
Varro Life Sciences is building momentum with the opening of its new St. Louis R&D facility. Backed by a $42.5 million investment and 33 new jobs, the company is accelerating its path toward breakthrough biosensor innovations and long-term growth.
For more coverage of the ribbon cutting ceremony, click here.
News and Updates
Get the Latest from Varro!
Fill out the form below and subscribe to our newsletter.
